We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Beijing Cancer Hospital Becomes First Hospital in China to Introduce New IMRT Radiotherapy Cancer Treatments

By HospiMedica International staff writers
Posted on 06 Aug 2009
Cancer patients in China are gaining access to fast and efficient radiotherapy treatments with the introduction of new image-guided intensity-modulated radiation therapy (IMRT) technology.

Beijing Cancer Hospital (BCH; China) is the first hospital in China to introduce the revolutionary technique, developed by Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA), which provides advanced care to a great number of patients. "The speed and precision of RapidArc makes it perfect for the heavy patient throughput that we see in China,” stated Dr. Guangying Zhu, professor of radiation oncology at BCH. "We will be able to treat more patients with the new RapidArc-equipped accelerator, which should certainly help to improve the regional control rate and offer significant benefits to patients.”

The new system was unveiled at a ribbon-cutting ceremony attended by many local dignitaries on July 10, 2009. Doctors at the hospital intend to use RapidArc primarily for precise treatments of lung cancer, esophagus cancer, rectal cancer, and head and neck cancer. RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided IMRT two to eight times faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery, and less time on the treatment couch, allows for greater patient comfort.

Beijing Cancer Hospital has treated more than 5,000 patients with conventional IMRT in recent years, gaining a global reputation for the quality of its treatments and the scientific papers published on its research. "Most IMRT treatments take between 15 and 30 minutes to deliver,” added Dr. Zhu. "With RapidArc we will be able to offer equivalent and even superior treatments in just two to three minutes. The high-performance On-Board Imager is an excellent targeting tool and the reliability of Varian's linear accelerators brings us a great deal of confidence for a high up-time system.”

Beijing Cancer Hospital's department of radiation oncology treats more than 2,000 new cancer patients each year from across China, as well as from neighboring countries such as Vietnam. According to Dr. Zhu, RapidArc will be particularly helpful in helping to decrease growing waiting lists at the hospital, with cancer rates rising considerably year-on-year. "There is a huge difference in the linear accelerator installed base between different areas of China. From a technology and expertise standpoint, large hospitals in China have advanced equipment and clinical expertise that is no different from that in more developed countries. We just have nowhere near enough capacity to meet our needs,” he noted. There are 12 machines per million people in the United States and only 0.7 machines per million people in China.

"RapidArc will help this busy public cancer center to treat more patients with advanced radiotherapy techniques,” said Tom Duffy, Varian's marketing director in China. "When implemented, RapidArc can enable hospitals to treat over 30% more patients on a linear accelerator each day.”

Dr. Jinming Yu, chairman of the China Society for Therapeutic Radiation and Oncology (CSTRO; Beijing), said, "RapidArc is the leading radiation therapy technique, especially for fast and precisely targeted treatments. I believe that this high-tech machine will provide excellent benefits for cancer patients in China.”

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a major supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.

Related Links:

Varian Medical Systems
Beijing Cancer Hospital





Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
PACS Workstation
PaxeraView PRO
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.